GALLENGA, Carla Enrica
 Distribuzione geografica
Continente #
NA - Nord America 2.413
AS - Asia 2.003
EU - Europa 1.209
SA - Sud America 355
AF - Africa 59
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.057
Nazione #
US - Stati Uniti d'America 2.315
SG - Singapore 698
IT - Italia 376
PL - Polonia 343
CN - Cina 319
BR - Brasile 262
VN - Vietnam 255
HK - Hong Kong 191
BD - Bangladesh 121
DE - Germania 108
IN - India 91
GB - Regno Unito 90
JP - Giappone 60
ID - Indonesia 57
FR - Francia 53
CA - Canada 46
FI - Finlandia 41
AR - Argentina 40
TR - Turchia 38
RU - Federazione Russa 36
MX - Messico 34
TH - Thailandia 32
UA - Ucraina 30
NL - Olanda 28
ES - Italia 24
SE - Svezia 22
IQ - Iraq 19
CO - Colombia 15
MY - Malesia 15
PK - Pakistan 14
AU - Australia 13
VE - Venezuela 13
ZA - Sudafrica 13
KR - Corea 11
EG - Egitto 10
IL - Israele 10
PH - Filippine 10
SA - Arabia Saudita 10
BE - Belgio 9
EC - Ecuador 9
AT - Austria 8
MA - Marocco 8
TN - Tunisia 8
UZ - Uzbekistan 8
CL - Cile 7
GR - Grecia 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
KZ - Kazakistan 6
NP - Nepal 6
AL - Albania 5
LT - Lituania 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
IE - Irlanda 4
JO - Giordania 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
RO - Romania 4
AZ - Azerbaigian 3
CR - Costa Rica 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
NO - Norvegia 3
OM - Oman 3
TW - Taiwan 3
UY - Uruguay 3
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
LV - Lettonia 2
LY - Libia 2
NI - Nicaragua 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NG - Nigeria 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RE - Reunion 1
Totale 6.056
Città #
Singapore 417
Ashburn 341
Warsaw 338
San Jose 296
Hong Kong 177
Fairfield 127
Santa Clara 120
Beijing 110
Chandler 97
Ho Chi Minh City 81
Woodbridge 80
Ann Arbor 75
Council Bluffs 68
Houston 65
Los Angeles 59
New York 57
Hanoi 56
Munich 54
Seattle 54
Milan 46
Tokyo 46
Wilmington 46
Cambridge 42
São Paulo 38
Jakarta 37
Dallas 36
Ferrara 35
Jacksonville 27
Lauterbourg 27
Pescara 25
Chicago 24
Orem 24
Denver 23
Princeton 20
Helsinki 19
Phoenix 19
Rome 19
Mexico City 18
Shanghai 18
Izmir 17
Da Nang 16
Verona 16
Boardman 15
Chennai 15
Brooklyn 14
Toronto 14
Montreal 13
Raipur 13
Redwood City 13
Turku 12
Atlanta 11
Buffalo 11
Haiphong 11
Bangkok 10
Frankfurt am Main 10
London 10
Stockholm 10
The Dalles 10
Bologna 9
Boston 9
Brussels 9
Hefei 9
Johannesburg 9
Norwich 9
Osaka 9
Poplar 9
San Diego 9
Amsterdam 8
Curitiba 8
Dong Ket 8
Mumbai 8
Nanjing 8
Naples 8
New Delhi 8
Paris 8
Adelaide 7
Biên Hòa 7
Cagliari 7
Chon Buri 7
Manchester 7
Nuremberg 7
Querétaro 7
Rio de Janeiro 7
San Francisco 7
Tashkent 7
Brasília 6
Buenos Aires 6
Columbus 6
Moscow 6
Phuket 6
Salt Lake City 6
Ankara 5
Baghdad 5
Bremen 5
Bắc Ninh 5
Cairo 5
City of London 5
Dublin 5
Falkenstein 5
Guangzhou 5
Totale 3.798
Nome #
Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study 422
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration 371
Determination of the soluble form of the P2X7 receptor in aqueous humour, vitreous humour and serum under normal and pathological conditions: sP2X7R as an indicator of ocular inflammatory status 360
Psoriatic uveitis is not an exploded myth 274
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 269
A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: A better understanding of the pathophysiology using the newest genetic strategies 265
Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection 233
The role of gene therapy in the treatment of retinal diseases: A review 223
A New Pharmacological Approach Based on Remdesivir Aerosolized Administration on SARS-CoV-2 Pulmonary Inflammation: A Possible and Rational Therapeutic Application 217
New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma 202
Diagnosis of a Neonatal Ophthalmic Discharge, Ophthalmia Neonatorum, in the “Molecular Age”: Investigation for a Correct Therapy 193
Inflammaging: should this term be suitable for age related macular degeneration too? 147
How to classify the covid-19 phenotype: a response from "the first soldier in the first trench" in Lombardy, north-western Italy 143
About Chlamydia trachomatis. Reply to Garcia-Teillard et al. Trachoma and the Importance of Sexual Infective Route in Developed Countries. Comment on “Gallenga et al. Why the SAFE—S Strategy for Trachoma? Are Musca sorbens or Scatophaga stercoraria Really the Culprit?—A Brief Historical Review from an Italian Point of View. Pathogens 2023, 12, 1419” 142
Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation 138
Evaluation of Anti-SARS-CoV-2 IgA Response in Tears of Vaccinated COVID-19 Subjects 134
Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines 133
Mast cell cytokines il-1, il-33, and il-36 mediate skin inflammation in psoriasis: A novel therapeutic approach with the anti-inflammatory cytokines il-37, il-38, and il-1ra 122
Retinitis pigmentosa and cystoid macular pattern 118
Mast cells mediate rheumatoid arthritis—inhibitory role of IL-37 112
Who is Afraid of a Bug Mantled Like Zorro? 99
Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37 99
New insight into systemic mastocytosis mediated by cytokines IL-1β and IL-33: Potential inhibitory effect of IL-37 97
Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37 95
Macrophage Activation in Follicular Conjunctivitis during the COVID-19 Pandemic 95
Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37 83
Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis 82
Why the SAFE—S Strategy for Trachoma? Are Musca sorbens or Scatophaga stercoraria Really the Culprit?—A Brief Historical Review from an Italian Point of View 78
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1 77
Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines 77
Floppy Iris Risk Factors 71
New aspect of allergic contact dermatitis, an inflammatory skin disorder mediated by mast cells: Can IL-38 help? 58
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy 54
Anaphylaxis is a rare reaction in COVID-19 vaccination 52
Molecular Mechanisms Related to Oxidative Stress in Retinitis Pigmentosa 52
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 50
CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37 46
Contribution of mast cells in SARS-CoV-2-induced inflammation 45
Inquadramento diagnostico dell’Orbitopatia di Graves 43
Activation of mast cells mediates inflammatory response in psoriasis: Potential new therapeutic approach with IL‐37 40
RETINAL PHAKOMATOSIS AND VON HIPPEL–LINDAU PERIPHERAL CAPILLARY HEMANGIOBLASTOMA: PROPOSAL FOR STAGED SURGERY 36
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra) 30
Novel evidence of ghrelin and growth hormone segretagogue receptor expression by human ocular tissues 28
Mast cells and virus 27
Suggestions on gut-eye cross-talk: about the chalazion 27
Interleukin-1 family cytokines and mast cells: activation and inhibition 26
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies 24
Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37 23
Mesenchymal stem cells and IL-37: a powerful combination 23
Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects 22
Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19 22
New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators 22
Mast cell virus infection and inflammatory cytokines 22
Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity 22
Powerful anti-inflammatory action of luteolin: Potential increase with IL-38 22
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19 21
Visual Performance and Quality of Life after Femtosecond Laser-Assisted Cataract Surgery with Trifocal IOLs Implantation 20
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem 20
Short term effects of extremely low irradiance photobiomodulation on retinal function, in age related macular degeneration 20
Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy 19
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines 18
SARS-CoV-2, which induces COVID-19, causes Kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines 17
Virtual learning solutions in COVID-19 era: University Italian Ophthalmology department perspective 17
Impact of mast cells in fibromyalgia and low‐grade chronic inflammation: Can IL‐37 play a role? 17
Impact of mold on mast cell-cytokine immune response 16
Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited? 12
Totale 6.184
Categoria #
all - tutte 27.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.272


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 0 0 22
2021/2022188 18 24 10 11 8 17 5 13 10 13 13 46
2022/2023244 19 15 13 18 33 25 39 21 29 10 11 11
2023/2024200 14 19 6 9 13 25 8 12 1 15 16 62
2024/2025948 24 20 84 31 95 113 25 45 148 93 120 150
2025/20263.536 278 111 294 521 444 253 337 218 337 428 258 57
Totale 6.184